ODI Pharma AB (ODI.ST)

SEK 2.76

(-8.0%)

Total Assets Summary of ODI Pharma AB

  • ODI Pharma AB's latest annual total assets in 2023 was 12.27 Million SEK , up 49.96% from previous year.
  • ODI Pharma AB's latest quarterly total assets in 2023 FY was 12.27 Million SEK , up 49.96% from previous quarter.
  • ODI Pharma AB reported annual total assets of 8.18 Million SEK in 2022, down -22.02% from previous year.
  • ODI Pharma AB reported annual total assets of 10.49 Million SEK in 2021, down -37.81% from previous year.
  • ODI Pharma AB reported quarterly total assets of 7.34 Million SEK for 2023 Q2, up 8.08% from previous quarter.
  • ODI Pharma AB reported quarterly total assets of 12.27 Million SEK for 2023 Q4, down -20.6% from previous quarter.

Annual Total Assets Chart of ODI Pharma AB (2023 - 2018)

Historical Annual Total Assets of ODI Pharma AB (2023 - 2018)

Year Total Assets Total Assets Growth
2023 12.27 Million SEK 49.96%
2022 8.18 Million SEK -22.02%
2021 10.49 Million SEK -37.81%
2020 16.88 Million SEK -19.09%
2019 20.86 Million SEK 366.76%
2018 4.46 Million SEK 0.0%

Peer Total Assets Comparison of ODI Pharma AB

Name Total Assets Total Assets Difference
AcuCort AB 58.5 Million SEK 79.02%
AlzeCure Pharma AB (publ) 32 Million SEK 61.642%
BioGaia AB (publ) 2.33 Billion SEK 99.474%
Enzymatica AB (publ) 125.91 Million SEK 90.251%
Enorama Pharma AB (publ) 34.38 Million SEK 64.301%
Gabather AB (publ) 2.93 Million SEK -317.943%
Klaria Pharma Holding AB (publ.) 73.12 Million SEK 83.213%
Moberg Pharma AB (publ) 634.73 Million SEK 98.066%
Nanexa AB (publ) 132.25 Million SEK 90.719%
Newbury Pharmaceuticals AB (publ) 90.87 Million SEK 86.492%
Orexo AB (publ) 786.6 Million SEK 98.439%
Probi AB (publ) 1.55 Billion SEK 99.208%
Swedencare AB (publ) 9.52 Billion SEK 99.871%
Swedish Orphan Biovitrum AB (publ) 74.02 Billion SEK 99.983%
Toleranzia AB 160.42 Million SEK 92.349%
Vivesto AB 355.87 Million SEK 96.551%